Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation of RMC-4630 Monotherapy in Relapsed/Refractory Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03634982
Recruitment Status : Recruiting
First Posted : August 17, 2018
Last Update Posted : October 19, 2020
Sponsor:
Collaborator:
Sanofi
Information provided by (Responsible Party):
Revolution Medicines, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 1, 2021
Estimated Study Completion Date : October 1, 2021